BSE - Delayed Quote INR

Aurobindo Pharma Limited (AUROPHARMA.BO)

Compare
1,211.85
-33.45
(-2.69%)
At close: January 24 at 3:29:17 PM GMT+5:30
All numbers in thousands
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
15,866,600.00
24,345,200.00
23,867,500.00
50,164,800.00
33,290,500.00
Investing Cash Flow
-19,029,200.00
-42,559,500.00
-39,777,500.00
-32,115,600.00
5,986,900.00
Financing Cash Flow
530,100.00
8,004,200.00
18,144,100.00
-29,692,700.00
-13,649,400.00
End Cash Position
38,656,400.00
33,854,300.00
43,922,700.00
41,625,100.00
53,299,100.00
Capital Expenditure
-23,626,600.00
-35,615,000.00
-27,204,000.00
-27,046,400.00
-18,738,100.00
Issuance of Debt
19,213,700.00
15,632,400.00
3,935,800.00
827,300.00
1,769,800.00
Repayment of Debt
-211,700.00
-171,700.00
-56,500.00
--
-11,359,400.00
Free Cash Flow
-7,760,000.00
-11,269,800.00
-3,336,500.00
23,118,400.00
14,552,400.00
3/31/2021 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers